(12) Patent Application Publication (10) Pub. No.: US 2011/0224164 A1 Lebreton (43) Pub

Total Page:16

File Type:pdf, Size:1020Kb

(12) Patent Application Publication (10) Pub. No.: US 2011/0224164 A1 Lebreton (43) Pub US 20110224164A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0224164 A1 Lebreton (43) Pub. Date: Sep. 15, 2011 (54) FLUID COMPOSITIONS FOR IMPROVING Publication Classification SKIN CONDITIONS (51) Int. Cl. (75) Inventor: Pierre F. Lebreton, Annecy (FR) 3G 0.O :08: (73) Assignee: Allergan Industrie, SAS, Pringy (FR) (52) U.S. Cl. .......................................................... 514/54 (21)21) Appl. NoNo.: 12/777,1069 (57) ABSTRACT (22) Filed: May 10, 2010 The present specification discloses fluid compositions com O O prising a matrix polymerand stabilizing component, methods Related U.S. Application Data of making Such fluid compositions, and methods of treating (60) Provisional application No. 61/313,664, filed on Mar. skin conditions in an individual using Such fluid composi 12, 2010. tions. Patent Application Publication Sep. 15, 2011 Sheet 1 of 3 US 2011/0224164 A1 girl is" . .... i E.- &;',EE 3 isre. fire;Sigis's Patent Application Publication Sep. 15, 2011 Sheet 2 of 3 US 2011/0224164 A1 Wiscosity"in a a set g : i?vs. iii.tige: ssp. r. E. site is Patent Application Publication Sep. 15, 2011 Sheet 3 of 3 US 2011/0224164 A1 Fi; ; ; ; , ; i 3 -i-...-- m M mommam mm M. M. MS ' ' s 6. ;:S - - - is : s s: s e 3. 83 8 is is a is É . ; i: ; ------es----- .- mm M. Ma Yum YM Mm - m - -W Mmm-m a 'm m - - - S. 'm - i. So m m 3 - - - - - - - - --- f ; : : ---- ' - - - - - - - - - - - - - - - . : 2. ----------- US 2011/0224164 A1 Sep. 15, 2011 FLUID COMPOSITIONS FOR IMPROVING 0004. The fluid compositions disclosed in the present SKIN CONDITIONS specification achieve this goal. Such fluid compositions com prise a matrix polymer and a stabilizing component that reduces or prevents in Vivo degradation of the matrix polymer. 0001. This patent application claims priority pursuant to Administration of the disclosed fluid compositions improves 35 U.S.C. S 119(e) to U.S. Provisional Patent Application Ser. skin conditions such as, e.g., hydration and the cutaneous No. 61/313,664 filed Mar. 12, 2010, which is hereby incor elasticity by compensating for the loss of the endogenous porated by reference in its entirety. polymer. 0002 Dermal fillers are useful in soft tissue and dermal 0005 Thus, aspects of the present specification provide a correction. One common polymer used in dermal filler com fluid composition comprising a matrix polymer and a stabi positions is hyaluronan, also known as hyaluronic acid (HA). lizing component. Matrix polymers useful to make Such fluid Although exhibiting excellent biocompatibility and affinity compositions include, without limitation, a glycosaminogly for water molecules, in its natural state, hyaluronan exhibits can (like chondroitin Sulfate, dermatan Sulfate, keratan Sul poor biomechanical properties as a dermal filler. Tezel and fate, hyaluronan) and lubricin. Stabilizing components useful Fredrickson, The Science of Hyaluronic Acid Dermal Fillers, J Cosmet Laser Ther. 10(1): 35-42 (2008); Kablik, et al., to make Such fluid compositions include, without limitation, Comparative Physical Properties of Hyaluronic Acid Dermal polyols and flavonoids. Fillers, Dermatol Surg. 35 Suppl 1:302-312 (2009); Beasley, 0006. Other aspects of the present specification provide a et al., Hyaluronic Acid Fillers: A Comprehensive Review, method of making a fluid composition disclosed in the Facial Plast Surg. 25(2): 86-94 (2009); each of which is present specification. In an aspect, a method for making a hereby incorporated by reference in its entirety. One primary fluid composition comprises the steps of: a) combining a reason is that this polymer is soluble and is cleared rapidly stabilizing component with a physiologically-acceptable when administered into a skin region. Tezel, supra, 2008: buffer to make a stabilizing component-buffered solution; Kablik, Supra, 2009; Beasley, supra, 2009. This in vivo clear and b) combining a matrix polymer with the stabilizing com ance is primarily achieved by degradation, principally enzy ponent-buffered solution to hydrate the matrix polymer. In matic degradation via hyaluronidase and chemical degrada another aspect, a method for making a fluid composition tion via free-radicals. To minimize the effect of these in vivo comprises the steps of: a) combining a stabilizing component degradation pathways, matrix polymers like hyaluronan are with a physiologically-acceptable buffer to make a stabilizing crosslinked to one another to form a hydrogel. Because component-buffered solution; b) combining a matrix poly hydrogels are more solid Substance that are readily soluble, mer with the stabilizing component-buffered solution to dermal fillers comprising such crosslinked matrix polymers hydrate the matrix polymer, and; c) sizing the fluid composi remain in place at the implant site. Tezel, supra, 2008; Kablik, tion. This method may, or may not, further comprise a step supra, 2009; Beasley, supra, 2009. A crosslinked matrix poly comprising titrating a stabilizing component-buffered solu mer like hyaluronan is also more Suitable as a component of tion to obtain a desired pH after step (a); a step comprising a dermal filler because it's more solid nature improves the filtering the stabilizing component-buffered solution after mechanical properties of the filler, allowing the filler to better step (a); a step (b) where combining a matrix polymer with the lift and fill a skin region. Tezel, supra, 2008; Kablik, supra, stabilizing component-buffered solution to hydrate the 2009; Beasley, supra, 2009. matrix polymer occurs by mixing the matrix polymer with the 0003 Hyaluronan is abundant in the different layers of the stabilizing component-buffered solution at a low speed for a skin, where it has multiple functions such as to ensure good relatively long period of time; a step (b) where combining a hydration, assist in the organization of the collagen matrix, matrix polymer with the stabilizing component-buffered and act as a filler material assisting the organization of the Solution to hydrate the matrix polymer occurs by mixing the extracellular matrix. However, with age, the quantity of matrix polymer with the stabilizing component-buffered hyaluronan present in the skin decreases. This lose of hyalu Solution at a low speed for a relatively long period of time and roman results in various skin conditions such as, e.g., skin then followed by a rest for a relative long period of time; a step dehydration, lack of skin elasticity, skin roughness, lack of (b) where combining a matrix polymer with the stabilizing skin tautness, skin stretch line and/or marks, skin paleness, component-buffered solution to hydrate the matrix polymer skin wrinkles, and the like. As such, it would be desirable to occurs by mixing the matrix polymer with the stabilizing have a skin therapy that can replace the endogenous matrix component-buffered solution at a low speed for a relatively polymers that are lost with age in order to treat these skin long period of time and then by mixing the matrix polymer conditions. However, current dermal fillers comprising with the stabilizing component-buffered solution using a hydrogels of crosslinked matrix polymers like crosslinked cycle of alternating periods of agitation for a relatively short hyaluronan cannot be used to replace the lost endogenous period of time followed by periods of rest for a relatively long polymers because the crosslinking prevents the ability of period of time; a step (b) where combining a matrix polymer these polymers to integrate into the extracellular matrix. with the stabilizing component-buffered solution to hydrate However, as discussed above, although uncrosslinked matrix the matrix polymer occurs by mixing the matrix polymer with polymers like hyaluronan are soluble, and as Such, could the stabilizing component-buffered solution at a low speed integrate into the extracellular matrix and replace lost endog for a relatively long period of time and then by mixing the enous hyaluronan, uncrosslinked matrix polymers are rapidly matrix polymer with the stabilizing component-buffered cleared from the body by in vivo degradation pathways. Thus, Solution using a cycle of alternating periods of agitation for a what is needed is a fluid composition comprising relatively short period of time followed by periods of rest for uncrosslinked matrix polymers that include an additional sta a relatively long period of time, and then followed by a rest for bilizing component that reduces or prevents matrix polymer a relative long period of time; a step comprising degassing a degradation. fluid composition after step (b) or step (c); a step comprising US 2011/0224164 A1 Sep. 15, 2011 filling a syringe with a fluid composition after step (c); and/or bilizing component. As used herein, the term “fluid refers to a step comprising sterilizing a syringe filled with a fluid a continuous, amorphous Substance whose molecules move composition after step (c). freely pastone another. A fluid cannot Sustain a shearing force 0007. Yet other aspects of the present specification pro when at rest and undergoes a continuous change in shape vide a fluid composition disclosed in the present specification when subjected to such a force. It should be noted, that made by a method disclosed in the present specification. although the compositions disclosed in the present specifica 0008 Still other aspects of the present specification pro tion are fluid in nature due to the presence of uncross linked vide a method of improving a condition of skin
Recommended publications
  • Walnut Polyphenol
    ORYZA OIL & FAT CHEMICAL CO., L TD. WALNUT POLYPHENOL Hepatoprotective & Anti-oxidative Extract For Metabolic Syndrome ■ WALNUT POLYPHENOL-P10,P30 (Powder,Food Grade) ■ WALNUT POLYPHENOL-WSP10 (Water-soluble Powder,Food Grade) ■ WALNUT POLYPHENOL-PC10,PC30 (Powder,Cosmetic Grade) ■ WALNUT POLYPHENOL-WSPC10 (Water-soluble Powder,Cosmetic Grade) ■ WALNUT POLYPHENOL-LC (Water-soluble Liquid,Cosmetic Grade) ■ WALNUT SEED OIL (Oil,Food & Cosmetic Grade) ORYZA OIL & FAT CHEMICAL CO., LTD ver. 1.0 HS WALNUT POLYPHENOL ver.1.0 HS WALNUT POLYPHENOL Hepatoprotective & Anti-oxidative Extract For Metabolic Syndrome 1. Introduction Recently, there is an increased awareness on metabolic syndrome – a condition characterized by a group of metabolic risk factors in one person. They include abdominal obesity, atherogenic dyslipidemia, elevated blood pressure, insulin resistance, prothrombotic state & proinflammatory state. The dominant underlying risk factors appear to be abdominal obesity and insulin resistance. In addition, non-alcoholic fatty liver disease (NAFLD) is the most commonly associated “liver” manifestation of metabolic syndrome which can progress to advance liver disease (e.g. cirrhosis) with associated morbidity and mortality. Lifestyle therapies such as weight loss significantly improve all aspects of metabolic syndrome, as well as reducing progression of NAFLD and cardiovascular mortality. Walnut (Juglans regia L. seed) is one the most popular nuts consumed in the world. It is loaded in polyunsaturated fatty acids – linoleic acid (LA), oleic acid and α-linolenic acid (ALA), an ω3 fatty acid. It has been used since ancient times and epidemiological studies have revealed that incorporating walnuts in a healthy diet reduces the risk of cardiovascular diseases. Recent investigations reported that walnut diet improves the function of blood vessels and lower serum cholesterol.
    [Show full text]
  • Biochanin a Promotes Proliferation That Involves a Feedback Loop of Microrna-375 and Estrogen Receptor Alpha in Breast Cancer Cells
    Cellular Physiology Cell Physiol Biochem 2015;35:639-646 DOI: 10.1159/000369725 © 2015 S. Karger AG, Basel and Biochemistry Published online: January 28, 2015 www.karger.com/cpb 639 Accepted:Chen et al.: December Biochanin 03, A Promotes 2014 Proliferation 1421-9778/15/0352-0639$39.50/0 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. Original Paper Biochanin A Promotes Proliferation that Involves a Feedback Loop of MicroRNA-375 and Estrogen Receptor Alpha in Breast Cancer Cells Jian Chena Bo Geb Yong Wanga Yu Yec Sien Zengd Zhaoquan Huangd aSchool of Basic Medical Sciences, Guilin Medical University, Guilin, bGuilin Medical University, Guilin, cDepartment of Emergency, First Affiliated Hospital of Guangxi Medical University, Nanning, dDepartment of Pathology, Guilin Medical University, Guilin, China Key Words Biochanin A • miR-375 • Estrogen receptor α • OVX Abstract Background: Biochanin A and formononetin are O-methylated isoflavones that are isolated from the root of Astragalus membranaceus, and have antitumorigenic effects. Our previous studies found that formononetin triggered growth-inhibitory and apoptotic activities in MCF-7 breast cancer cells. We performed in vivo and in vitro studies to further investigate the potential effect of biochanin A in promoting cell proliferation in estrogen receptor (ER)- positive cells, and to elucidate underlying mechanisms. Methods: ERα-positive breast cancer cells (T47D, MCF-7) were treated with biochanin A. The MTT assay and flow cytometry were used to assess cell proliferation and apoptosis.
    [Show full text]
  • Protection of PC12 Cells Against Superoxide-Induced Damage by Isoflavonoids from Astragalus Mongholicus1
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES 22, 50-54 (2009) www.besjournal.com Protection of PC12 Cells against Superoxide-induced Damage by 1 Isoflavonoids from Astragalus mongholicus # + + #,2 DE-HONG YU , YONG-MING BAO , LI-JIA AN , AND MING YANG #The State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100083, China; +Department of Bioscience and Biotechnology, Dalian University of Technology, Dalian 116024, Liaoning, China Objective To further investigate the neuroprotective effects of five isoflavonoids from Astragalus mongholicus on xanthine (XA)/ xanthine oxidase (XO)-induced injury to PC12 cells. Methods PC12 cells were damaged by XA/XO. The activities of antioxidant enzymes, MTT, LDH, and GSH assays were used to evaluate the protection of these five isoflavonoids. Contents of Bcl-2 family proteins were determined with flow cytometry. Results Among the five isoflavonoids including formononetin, ononin, 9, 10-dimethoxypterocarpan-3-O-β-D-glucoside, calycosin and calycosin-7-O-glucoside, calycosin and calycosin-7-O-glucoside were found to inhibit XA/ XO-induced injury to PC12 cells. Their EC50 values of formononetin and calycosin were 0.05 μg/mL. Moreover, treatment with these three isoflavonoids prevented a decrease in the activities of antioxidant enzymes, superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), while formononetin and calycosin could prevent a significant deletion of GSH. In addition, only calycosin and calycosin-7-O-glucoside were shown to inhibit XO activity in cell-free system, with an approximate IC50 value of 10 μg/mL and 50 μg/mL. Formononetin and calycosin had no significant influence on Bcl-2 or Bax protein contents. Conclusion Neuroprotection of formononetin, calycosin and calycosin-7-O-glucoside may be mediated by increasing endogenous antioxidants, rather by inhibiting XO activities or by scavenging free radicals.
    [Show full text]
  • Tannins: Current Knowledge of Food Sources, Intake, Bioavailability and Biological Effects
    S310 DOI 10.1002/mnfr.200900039 Mol. Nutr. Food Res. 2009, 53, S310 – S329 Review Tannins: Current knowledge of food sources, intake, bioavailability and biological effects Jos Serrano1, Riitta Puupponen-Pimi2, Andreas Dauer3, Anna-Marja Aura2 and Fulgencio Saura-Calixto4 1 Universidad Complutense de Madrid, Depto. Nutricin y Bromatologa I, Madrid, Spain 2 VTT Technical Research Center of Finland 3 Hexal AG, Holzkirchen, Germany 4 Consejo Superior de Investigaciones Cientficas, Instituto del Frio, Depto. Metabolismo y Nutricin, Madrid, Spain Tannins are a unique group of phenolic metabolites with molecular weights between 500 and 30000 Da, which are widely distributed in almost all plant foods and beverages. Proanthocyanidins and hydrolysable tannins are the two major groups of these bioactive compounds, but complex tannins containing structural elements of both groups and specific tannins in marine brown algae have also been described. Most literature data on food tannins refer only to oligomeric compounds that are extracted with aqueous-organic solvents, but a significant number of non-extractable tannins are usu- ally not mentioned in the literature. The biological effects of tannins usually depend on their grade of polymerisation and solubility. Highly polymerised tannins exhibit low bioaccessibility in the small intestine and low fermentability by colonic microflora. This review summarises a new approach to analysis of extractable and non-extractable tannins, major food sources, and effects of storage and processing on tannin content and bioavailability. Biological properties such as antioxidant, antimicro- bial and antiviral effects are also described. In addition, the role of tannins in diabetes mellitus has been discussed. Keywords: Bioavailability / Diet / Hydrolysable tannins / Proanthocyanidins / Tannins / Received: November 27, 2007; revised: January 25, 2009; accepted: February 9, 2009 1 Introduction weight having the ability to complex strongly with carbohy- drates and proteins [9].
    [Show full text]
  • The Use of Plants in the Traditional Management of Diabetes in Nigeria: Pharmacological and Toxicological Considerations
    Journal of Ethnopharmacology 155 (2014) 857–924 Contents lists available at ScienceDirect Journal of Ethnopharmacology journal homepage: www.elsevier.com/locate/jep Review The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations Udoamaka F. Ezuruike n, Jose M. Prieto 1 Center for Pharmacognosy and Phytotherapy, Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, 29-39 Brunswick Square, WC1N 1AX London, United Kingdom article info abstract Article history: Ethnopharmacological relevance: The prevalence of diabetes is on a steady increase worldwide and it is Received 15 November 2013 now identified as one of the main threats to human health in the 21st century. In Nigeria, the use of Received in revised form herbal medicine alone or alongside prescription drugs for its management is quite common. We hereby 26 May 2014 carry out a review of medicinal plants traditionally used for diabetes management in Nigeria. Based on Accepted 26 May 2014 the available evidence on the species' pharmacology and safety, we highlight ways in which their Available online 12 June 2014 therapeutic potential can be properly harnessed for possible integration into the country's healthcare Keywords: system. Diabetes Materials and methods: Ethnobotanical information was obtained from a literature search of electronic Nigeria databases such as Google Scholar, Pubmed and Scopus up to 2013 for publications on medicinal plants Ethnopharmacology used in diabetes management, in which the place of use and/or sample collection was identified as Herb–drug interactions Nigeria. ‘Diabetes’ and ‘Nigeria’ were used as keywords for the primary searches; and then ‘Plant name – WHO Traditional Medicine Strategy accepted or synonyms’, ‘Constituents’, ‘Drug interaction’ and/or ‘Toxicity’ for the secondary searches.
    [Show full text]
  • WO 2017/210163 Al 07 December 2017 (07.12.2017) W !P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/210163 Al 07 December 2017 (07.12.2017) W !P O PCT (51) International Patent Classification: (72) Inventor: DOUGHAN, Ben; 5400 Corporate Circle, A01N 63/00 (2006.01) C12N 1/14 (2006.01) Salem, Virginia 24153 (US). CI2N 1/04 (2006.01) (74) Agent: RUCKER, Adam L et al; Novozymes North (21) International Application Number: America, Inc., 77 Perry Chapel Church Rd., P.O. Box 576, PCT/US20 17/03495 1 Franklinton, North Carolina 27525 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 30 May 2017 (30.05.2017) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (25) Filing Language: English CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (26) Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, (30) Priority Data: KW,KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, 31 May 2016 (3 1.05.2016) 62/343,217 US MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, 62/347,773 09 June 2016 (09.06.2016) US PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 62/5 11,408 26 May 2017 (26.05.2017) us SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, TR, (71) Applicant: NOVOZYMES BIOAG A S [DK/DK]; TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Chemistry and Pharmacology of Kinkéliba (Combretum
    CHEMISTRY AND PHARMACOLOGY OF KINKÉLIBA (COMBRETUM MICRANTHUM), A WEST AFRICAN MEDICINAL PLANT By CARA RENAE WELCH A Dissertation submitted to the Graduate School-New Brunswick Rutgers, The State University of New Jersey in partial fulfillment of the requirements for the degree of Doctor of Philosophy Graduate Program in Medicinal Chemistry written under the direction of Dr. James E. Simon and approved by ______________________________ ______________________________ ______________________________ ______________________________ New Brunswick, New Jersey January, 2010 ABSTRACT OF THE DISSERTATION Chemistry and Pharmacology of Kinkéliba (Combretum micranthum), a West African Medicinal Plant by CARA RENAE WELCH Dissertation Director: James E. Simon Kinkéliba (Combretum micranthum, Fam. Combretaceae) is an undomesticated shrub species of western Africa and is one of the most popular traditional bush teas of Senegal. The herbal beverage is traditionally used for weight loss, digestion, as a diuretic and mild antibiotic, and to relieve pain. The fresh leaves are used to treat malarial fever. Leaf extracts, the most biologically active plant tissue relative to stem, bark and roots, were screened for antioxidant capacity, measuring the removal of a radical by UV/VIS spectrophotometry, anti-inflammatory activity, measuring inducible nitric oxide synthase (iNOS) in RAW 264.7 macrophage cells, and glucose-lowering activity, measuring phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression in an H4IIE rat hepatoma cell line. Radical oxygen scavenging activity, or antioxidant capacity, was utilized for initially directing the fractionation; highlighted subfractions and isolated compounds were subsequently tested for anti-inflammatory and glucose-lowering activities. The ethyl acetate and n-butanol fractions of the crude leaf extract were fractionated leading to the isolation and identification of a number of polyphenolic ii compounds.
    [Show full text]
  • Specialty Sorghums for Gluten Free Foods
    SPECIALTY SORGHUMS FOR HEALTHY FOODS Dr. LLOYD W. ROONEY, Professor and Faculty Fellow Dr. JOSEPH M. AWIKA, Research Associate Cereal Quality Lab, Soil & Crop Sciences Dept. Texas A&M University 2474 TAMUS College Station, Texas 77843-2474 1 I. INTRODUCTION Sorghum is a major crop used for food, feed and industrial purposes worldwide. In the Western Hemisphere it is mainly used as a livestock feed and has not been considered a significant ingredient in foods. With over 40,000 accessions in the world collection, tremendous diversity exists in sorghum in both composition and processing properties. The kernel varies in size, shape, color, density, hardness, composition, processing properties, taste and texture and nutritional value. This chapter reviews information on new food sorghums and other special sorghums with unique properties that could be used in producing a wide variety of food products for specialty markets and health foods. The paper will emphasize white food sorghum hybrids and special tannin and black sorghums with high levels of phytochemicals. These special sorghum varieties are an excellent source of nutraceuticals that can compete effectively with fruits and vegetable sources. In addition, we will indicate other opportunities for producing healthy foods from sorghum. A. Sorghum production Sorghum is the fifth most important cereal crop grown in the world. It is a major food grain in Africa and parts of India and China. In 2003, 42.1 million hectares of sorghum were harvested worldwide, with a total production of 54.7 million metric tons. United States, India, and Nigeria are the largest producers of sorghum representing approximately 19.2%, 14.5%, and 14.5% of the total world production, respectively, in 2003.
    [Show full text]
  • Ultrasound-Assisted Extraction Optimization Using
    a ISSN 0101-2061 (Print) Food Science and Technology ISSN 1678-457X (Online) DOI: https://doi.org/10.1590/fst.13421 Berberis crataegina DC. as a novel natural food colorant source: ultrasound-assisted extraction optimization using response surface methodology and thermal stability studies Mehmet DEMIRCI1,2 , Merve TOMAS1 , Zeynep Hazal TEKIN-ÇAKMAK2 , Salih KARASU2* Abstract This study aimed to investigate the potential use of anthocyanin of Berberis crataegina DC. as a natural food coloring agent in the food industry. For this aim, the ultrasound-assisted extraction (UAE) method was performed to extract anthocyanin of Berberis crataegina DC. The effect of ultrasound power 1(X : 20-100%), extraction temperature (X2: 20-60 °C), and time (X3: 10-20 min) on TPC and TAC of Berberis crataegina DC. extracts were examined and optimized by applying the Box–Behnken experimental design (BBD) with the response surface methodology (RSM). The influence of three independent variables and their combinatorial interactions on TPC and TAC were investigated by the quadratic models (R2: 0.9638&0.9892 and adj R2:0.9171&0.9654, respectively). The optimum conditions were determined as the amplitude level of 98%, the temperature of 57.41 °C, and extraction time of 13.86 min. The main anthocyanin compounds were identified, namely, Delphinidin-3-O- galactoside, Cyanidin-3-O-glucoside, Cyanidin-3-O-rutinoside, Petunidin-3-O-glucoside, Pelargonidin-3-O-glucoside, and Peonidin-3-O-glucoside. The anthocyanin degradation showed first-order kinetic, degradation rate constant (k), the half-life values (t1/2), and loss (%) were significantly affected by different temperatures (P < 0.05).
    [Show full text]
  • Flavonoid Glucodiversification with Engineered Sucrose-Active Enzymes Yannick Malbert
    Flavonoid glucodiversification with engineered sucrose-active enzymes Yannick Malbert To cite this version: Yannick Malbert. Flavonoid glucodiversification with engineered sucrose-active enzymes. Biotechnol- ogy. INSA de Toulouse, 2014. English. NNT : 2014ISAT0038. tel-01219406 HAL Id: tel-01219406 https://tel.archives-ouvertes.fr/tel-01219406 Submitted on 22 Oct 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Last name: MALBERT First name: Yannick Title: Flavonoid glucodiversification with engineered sucrose-active enzymes Speciality: Ecological, Veterinary, Agronomic Sciences and Bioengineering, Field: Enzymatic and microbial engineering. Year: 2014 Number of pages: 257 Flavonoid glycosides are natural plant secondary metabolites exhibiting many physicochemical and biological properties. Glycosylation usually improves flavonoid solubility but access to flavonoid glycosides is limited by their low production levels in plants. In this thesis work, the focus was placed on the development of new glucodiversification routes of natural flavonoids by taking advantage of protein engineering. Two biochemically and structurally characterized recombinant transglucosylases, the amylosucrase from Neisseria polysaccharea and the α-(1→2) branching sucrase, a truncated form of the dextransucrase from L. Mesenteroides NRRL B-1299, were selected to attempt glucosylation of different flavonoids, synthesize new α-glucoside derivatives with original patterns of glucosylation and hopefully improved their water-solubility.
    [Show full text]
  • Karanja” Belonging to Family Leguminosae
    Int. J. Pharm. Sci. Rev. Res., 59(1), November - December 2019; Article No. 05, Pages: 22-29 ISSN 0976 – 044X Review Article The Review: Phytochemical and Bioactive Screening of “Karanja” belonging to family Leguminosae. Preethima G1*, Ananda V 1, D. Visagaperumal 1, Vineeth Chandy 1, Prashanthi P 2 1Department of Pharmaceutical chemistry, T. John College of Pharmacy, Bangalore, India. 2Department of Pharmacognosy, T. John College of Pharmacy, Bangalore, Karnataka, India. *Corresponding author’s E-mail: [email protected] Received: 10-09-2019; Revised: 22-10-2019; Accepted: 03-11-2019. ABSTRACT Traditional medicine consists of huge number of plants with different pharmacological and medicinal values. The bioactive molecules have been identified. Pongamia pinnata (Linn.) Pierre is one of the oldest plants with numerous properties, which is found all over the globe. It is commonly known as “Indian beech tree” and has been identified in Ayurvedic and Siddha system of medicines for the healing effect of human beings. Different parts of whole plant are used for treatment of various diseases including rheumatism, diarrhoea, gonorrhoea, whooping cough, leprosy and bronchitis. Extracts of the whole plant show significant anti- plasmodial, anti-ulcerogenic, anti-diarrhoeal, anti-inflammatory, anti-fungal, and analgesic activities. Its oil is used as a source of biodiesel. The present review paper was aimed to u0pdate the information of Pongamia pinnata with reference to its pharmacological properties, chemical constituents and its use as anti-urolithiatic agent for the treatment of Urolithiasis. Keywords: Pongamia pinata, Indian beech tree, Healing effect, Anti-urolithiatic agent, urolithiasis. INTRODUCTION four- to five-toothed, with a papilionaceous corolla.
    [Show full text]
  • Food & Function
    Food & Function View Article Online REVIEW View Journal | View Issue Roles of proanthocyanidin rich extracts in obesity Cite this: Food Funct., 2015, 6, 1053 M. Josepa Salvadó,* Ester Casanova, Anabel Fernández-Iglesias, Lluis Arola and Cinta Bladé Obesity is a multifactorial disorder involving an abnormal or excessive amount of body fat. Obese people have a very high probability of developing metabolic syndrome, a condition in which cholesterol, lipid, and glucose levels rise, causing diabetes and heart disease. From the point of view of energy balance, the main contributors to obesity are excessive energy intake, inadequate energy expenditure and metabolic malfunctions. For this reason, health organisations are working to implement policies and plans to promote healthy eating and active living. However, these measures have not yet proven sufficient to combat this worldwide epidemic; therefore, drugs and bioactive compounds are being investigated to complement the existing strategies. In the present review, we discuss the available data regarding the Received 13th November 2014, modulation of obesity by proanthocyanidin rich extracts. Because studies with human subjects are very Accepted 22nd January 2015 scarce, we focus on studies using laboratory animals. The results of in vitro studies are included because, Creative Commons Attribution-NonCommercial 3.0 Unported Licence. DOI: 10.1039/c4fo01035c although they cannot be directly extrapolated to the biological effects of proanthocyanidin, they can www.rsc.org/foodfunction reveal some mechanisms
    [Show full text]